Hunter C Smith
CIK 1636385 · Chief Financial Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$10.57M
Companies
4
Total Filings
73
Lifetime Open-Market Net
-$12.80M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RYTM | Chief Financial Officer | 119,611 | $88.38 | $10.57M | -$12.80M | 45 | 2026-05-20 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Director | — | $12.01 | — | $0 | 3 | 2023-06-30 |
| GENESEE & WYOMING INC (GWR) Delisted | Director | 0 | — | — | $0 | 22 | 2019-12-30 |
| GENESEE & WYOMING INC (GWRU) Delisted | Director | 1,226 | — | — | $0 | 3 | 2015-07-02 |
Recent Filings · Page 4 of 8
73 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-06-09 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-15 | RYTM | Mixed | +1,511 | -$5.1K | EDGAR |
| 2022-02-11 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2021-11-16 | Spyre Therapeutics, Inc. (AGLE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-23 | RYTM | Exer (M) | +5,000 | $34.4K | EDGAR |
| 2021-02-16 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2021-01-20 | RYTM | Exer (M) | +4,000 | $27.5K | EDGAR |
| 2020-07-21 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | RYTM | Grant (A) | — | $0 | EDGAR |
| 2020-03-31 | RYTM | Exer (M) | +3,900 | $26.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.